Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 10.58%
- Poor long term growth as Net Sales has grown by an annual rate of 76.53% and Operating profit at 73.67% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.43%
0%
-7.43%
6 Months
5.0%
0%
5.0%
1 Year
107.17%
0%
107.17%
2 Years
70.69%
0%
70.69%
3 Years
7.69%
0%
7.69%
4 Years
-48.34%
0%
-48.34%
5 Years
-59.91%
0%
-59.91%
Seach Medical Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
76.53%
EBIT Growth (5y)
73.67%
EBIT to Interest (avg)
3.12
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
1.69
Tax Ratio
6.02%
Dividend Payout Ratio
30.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.58%
ROE (avg)
4.64%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.15
EV to EBIT
6.54
EV to EBITDA
5.05
EV to Capital Employed
1.18
EV to Sales
0.57
PEG Ratio
0.48
Dividend Yield
0.31%
ROCE (Latest)
18.09%
ROE (Latest)
8.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
40.90
42.60
-3.99%
Operating Profit (PBDIT) excl Other Income
6.50
4.00
62.50%
Interest
0.40
0.50
-20.00%
Exceptional Items
3.30
-0.10
3,400.00%
Consolidate Net Profit
4.20
2.30
82.61%
Operating Profit Margin (Excl OI)
137.10%
65.70%
7.14%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -3.99% vs 14.52% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 82.61% vs 187.50% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
171.70
150.30
14.24%
Operating Profit (PBDIT) excl Other Income
19.40
4.90
295.92%
Interest
2.30
2.70
-14.81%
Exceptional Items
4.10
-3.70
210.81%
Consolidate Net Profit
13.60
-11.90
214.29%
Operating Profit Margin (Excl OI)
84.10%
-8.10%
9.22%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 14.24% vs 12.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 214.29% vs -124.53% in Dec 2023






